# T cell subsets in inflammatory bowel disease

> **NIH VA I01** · VA SAN DIEGO HEALTHCARE SYSTEM · 2022 · —

## Abstract

Summary
The inflammatory bowel diseases (IBD) are chronic, incurable conditions that contribute to significant morbidity
and mortality in the Veteran population. Current therapies are effective long-term in only ~25% of patients with
IBD, suggesting that as yet unknown immune cell subsets may be involved in the initial development and
relapsing-remitting nature of IBD. We propose to elucidate T cell subsets that may play a role in the
pathophysiology of IBD; this work may ultimately lead to new therapeutic targets for IBD.

## Key facts

- **NIH application ID:** 10364307
- **Project number:** 1I01CX002396-01
- **Recipient organization:** VA SAN DIEGO HEALTHCARE SYSTEM
- **Principal Investigator:** John T Chang
- **Activity code:** I01 (R01, R21, SBIR, etc.)
- **Funding institute:** VA
- **Fiscal year:** 2022
- **Award amount:** —
- **Award type:** 1
- **Project period:** 2022-04-01 → 2026-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10364307

## Citation

> US National Institutes of Health, RePORTER application 10364307, T cell subsets in inflammatory bowel disease (1I01CX002396-01). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10364307. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*